PharVision Advisers »

Xylem shares owned by PharVision Advisers

Quarter-by-quarter ownership of Xylem (XYL) shares owned by PharVision Advisers from 13F filings

Historical chart of PharVision Advisers investment in Xylem

Tip: Access up to 7 years of quarterly data

All positions including Xylem held by PharVision Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Xylem by PharVision Advisers

Quarter filed Position value Share count Share price at filing
2025-12-31 $356k 2.6k 136.18
2025-06-30 $261k 2.0k 129.36

More positions owned by PharVision Advisers

ExlService Holdings (EXLS)
Delek Us Holdings (DK)
Fiverr Intl Ord Shs (FVRR)
Asana Cl A (ASAN)
Broadcom (AVGO)
Itron (ITRI)
Brinker International (EAT)
Herbalife Com Shs (HLF)
NVIDIA Corporation (NVDA)
Evolv Technologies Hldngs In Com Cl A (EVLV)
Las Vegas Sands (LVS)
Vici Pptys (VICI)
Century Aluminum Company (CENX)
Agilent Technologies Inc C ommon (A)
Vail Resorts (MTN)

View all positions for PharVision Advisers

Top funds holding Xylem

J. Stern & Co
Vanguard Group
BlackRock
State Street Corporation
Geode Capital Management
Swedbank AB
Amundi
Pictet Asset Management Holding SA
Impax Asset Management Group
Royal Bank of Canada
Ubs Global Asset Management Americas
Northern Trust
Invesco
Artisan Partners Limited Partnership
Victory Capital Management

View all funds holding Xylem